Severity of COPD and its relationship with IL-10

Detalhes bibliográficos
Autor(a) principal: Silva, Bruna S.A. [UNESP]
Data de Publicação: 2018
Outros Autores: Lira, Fábio S. [UNESP], Ramos, Dionei [UNESP], Uzeloto, Juliana S. [UNESP], Rossi, Fabrício Eduardo, Freire, Ana Paula C.F. [UNESP], Silva, Rebeca N. [UNESP], Trevisan, Iara B. [UNESP], Gobbo, Luis Alberto [UNESP], Ramos, Ercy M.C. [UNESP]
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNESP
Texto Completo: http://dx.doi.org/10.1016/j.cyto.2017.10.018
http://hdl.handle.net/11449/179329
Resumo: Background: The present study was designed to compare inflammatory and metabolic responses according to severity of airflow among patients with COPD and to verify the relationship between pulmonary function, body composition, metabolic and inflammatory profile. Methods: Fifty-one patients with mild to very severe COPD were recruited and divided according lung function in Mild-moderate (GOLD 1–2) n = 21; Severe (GOLD 3) n = 25 and Very severe (GOLD 4) n = 5. Patients were submitted to assessments of lung function (spirometry), functional exercise capacity (6-min walk test), body composition (Octopolar bioelectrical impedance), metabolic profile (glucose, triglycerides, total cholesterol, HDL-cholesterol and albumin (colorimetric assay)) and inflammatory profile (cytokines: IL-6, IL-10, TNF-α and IL-15 (ELISA)). Results: We found that patients in GOLD 3 group had lower levels of IL-10, triglycerides, visceral fat area, and higher IL-6 and IL-6/IL-10 ratio when compared to GOLD 1–2 patients. Additionally, GOLD 1–2 group presented negative correlation between TNF-α and HDL cholesterol (p =.01) and positive correlation between IL-15 and FEV1/FVC (p =.01), while GOLD 3 group showed positive correlation between IL-6 and IL-10 (p <.01), IL-6 and total cholesterol (p <.01) and negative correlation between IL-10 and HDL-cholesterol (p =.01). Conclusion: Our findings suggest that patients with severe COPD can exhibit compromised “inflammatory status” characterized by higher IL6, IL-6/IL-10 ratio and lower IL-10 concentration. Furthermore, IL-10 seems to be an interesting cytokine to be investigated in this kind of patients.
id UNSP_9dcd82ac7a6488291aa3ed41e5883e3a
oai_identifier_str oai:repositorio.unesp.br:11449/179329
network_acronym_str UNSP
network_name_str Repositório Institucional da UNESP
repository_id_str 2946
spelling Severity of COPD and its relationship with IL-10COPDCytokineEmphysemaInflammationMetabolic responseBackground: The present study was designed to compare inflammatory and metabolic responses according to severity of airflow among patients with COPD and to verify the relationship between pulmonary function, body composition, metabolic and inflammatory profile. Methods: Fifty-one patients with mild to very severe COPD were recruited and divided according lung function in Mild-moderate (GOLD 1–2) n = 21; Severe (GOLD 3) n = 25 and Very severe (GOLD 4) n = 5. Patients were submitted to assessments of lung function (spirometry), functional exercise capacity (6-min walk test), body composition (Octopolar bioelectrical impedance), metabolic profile (glucose, triglycerides, total cholesterol, HDL-cholesterol and albumin (colorimetric assay)) and inflammatory profile (cytokines: IL-6, IL-10, TNF-α and IL-15 (ELISA)). Results: We found that patients in GOLD 3 group had lower levels of IL-10, triglycerides, visceral fat area, and higher IL-6 and IL-6/IL-10 ratio when compared to GOLD 1–2 patients. Additionally, GOLD 1–2 group presented negative correlation between TNF-α and HDL cholesterol (p =.01) and positive correlation between IL-15 and FEV1/FVC (p =.01), while GOLD 3 group showed positive correlation between IL-6 and IL-10 (p <.01), IL-6 and total cholesterol (p <.01) and negative correlation between IL-10 and HDL-cholesterol (p =.01). Conclusion: Our findings suggest that patients with severe COPD can exhibit compromised “inflammatory status” characterized by higher IL6, IL-6/IL-10 ratio and lower IL-10 concentration. Furthermore, IL-10 seems to be an interesting cytokine to be investigated in this kind of patients.Skeletal Muscle Assessment Laboratory (LABSIM) São Paulo State University (UNESP) School of Technology and Sciences Department of Physcial EducationPost Graduation Program in Motricity Sciences São Paulo State University (UNESP) School of Technology and SciencesExercise and Immunometabolism Research Group Department of Physical Education São Paulo State University (UNESP) School of Technology and SciencesDepartment of Physical Therapy São Paulo State University (UNESP) School of Technology and SciencesPost Graduation Program in Physical Therapy São Paulo State University (UNESP) School of Technology and SciencesImmunometabolism of Skeletal Muscle and Exercise Research Group Department of Physical Education Federal University of Piauí (UFPI)Skeletal Muscle Assessment Laboratory (LABSIM) São Paulo State University (UNESP) School of Technology and Sciences Department of Physcial EducationPost Graduation Program in Motricity Sciences São Paulo State University (UNESP) School of Technology and SciencesExercise and Immunometabolism Research Group Department of Physical Education São Paulo State University (UNESP) School of Technology and SciencesDepartment of Physical Therapy São Paulo State University (UNESP) School of Technology and SciencesPost Graduation Program in Physical Therapy São Paulo State University (UNESP) School of Technology and SciencesUniversidade Estadual Paulista (Unesp)Federal University of Piauí (UFPI)Silva, Bruna S.A. [UNESP]Lira, Fábio S. [UNESP]Ramos, Dionei [UNESP]Uzeloto, Juliana S. [UNESP]Rossi, Fabrício EduardoFreire, Ana Paula C.F. [UNESP]Silva, Rebeca N. [UNESP]Trevisan, Iara B. [UNESP]Gobbo, Luis Alberto [UNESP]Ramos, Ercy M.C. [UNESP]2018-12-11T17:34:44Z2018-12-11T17:34:44Z2018-06-01info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article95-100application/pdfhttp://dx.doi.org/10.1016/j.cyto.2017.10.018Cytokine, v. 106, p. 95-100.1096-00231043-4666http://hdl.handle.net/11449/17932910.1016/j.cyto.2017.10.0182-s2.0-850328846732-s2.0-85032884673.pdf6550959666011238Scopusreponame:Repositório Institucional da UNESPinstname:Universidade Estadual Paulista (UNESP)instacron:UNESPengCytokine1,4331,433info:eu-repo/semantics/openAccess2024-06-18T18:44:41Zoai:repositorio.unesp.br:11449/179329Repositório InstitucionalPUBhttp://repositorio.unesp.br/oai/requestopendoar:29462024-08-05T23:23:23.544790Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)false
dc.title.none.fl_str_mv Severity of COPD and its relationship with IL-10
title Severity of COPD and its relationship with IL-10
spellingShingle Severity of COPD and its relationship with IL-10
Silva, Bruna S.A. [UNESP]
COPD
Cytokine
Emphysema
Inflammation
Metabolic response
title_short Severity of COPD and its relationship with IL-10
title_full Severity of COPD and its relationship with IL-10
title_fullStr Severity of COPD and its relationship with IL-10
title_full_unstemmed Severity of COPD and its relationship with IL-10
title_sort Severity of COPD and its relationship with IL-10
author Silva, Bruna S.A. [UNESP]
author_facet Silva, Bruna S.A. [UNESP]
Lira, Fábio S. [UNESP]
Ramos, Dionei [UNESP]
Uzeloto, Juliana S. [UNESP]
Rossi, Fabrício Eduardo
Freire, Ana Paula C.F. [UNESP]
Silva, Rebeca N. [UNESP]
Trevisan, Iara B. [UNESP]
Gobbo, Luis Alberto [UNESP]
Ramos, Ercy M.C. [UNESP]
author_role author
author2 Lira, Fábio S. [UNESP]
Ramos, Dionei [UNESP]
Uzeloto, Juliana S. [UNESP]
Rossi, Fabrício Eduardo
Freire, Ana Paula C.F. [UNESP]
Silva, Rebeca N. [UNESP]
Trevisan, Iara B. [UNESP]
Gobbo, Luis Alberto [UNESP]
Ramos, Ercy M.C. [UNESP]
author2_role author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Universidade Estadual Paulista (Unesp)
Federal University of Piauí (UFPI)
dc.contributor.author.fl_str_mv Silva, Bruna S.A. [UNESP]
Lira, Fábio S. [UNESP]
Ramos, Dionei [UNESP]
Uzeloto, Juliana S. [UNESP]
Rossi, Fabrício Eduardo
Freire, Ana Paula C.F. [UNESP]
Silva, Rebeca N. [UNESP]
Trevisan, Iara B. [UNESP]
Gobbo, Luis Alberto [UNESP]
Ramos, Ercy M.C. [UNESP]
dc.subject.por.fl_str_mv COPD
Cytokine
Emphysema
Inflammation
Metabolic response
topic COPD
Cytokine
Emphysema
Inflammation
Metabolic response
description Background: The present study was designed to compare inflammatory and metabolic responses according to severity of airflow among patients with COPD and to verify the relationship between pulmonary function, body composition, metabolic and inflammatory profile. Methods: Fifty-one patients with mild to very severe COPD were recruited and divided according lung function in Mild-moderate (GOLD 1–2) n = 21; Severe (GOLD 3) n = 25 and Very severe (GOLD 4) n = 5. Patients were submitted to assessments of lung function (spirometry), functional exercise capacity (6-min walk test), body composition (Octopolar bioelectrical impedance), metabolic profile (glucose, triglycerides, total cholesterol, HDL-cholesterol and albumin (colorimetric assay)) and inflammatory profile (cytokines: IL-6, IL-10, TNF-α and IL-15 (ELISA)). Results: We found that patients in GOLD 3 group had lower levels of IL-10, triglycerides, visceral fat area, and higher IL-6 and IL-6/IL-10 ratio when compared to GOLD 1–2 patients. Additionally, GOLD 1–2 group presented negative correlation between TNF-α and HDL cholesterol (p =.01) and positive correlation between IL-15 and FEV1/FVC (p =.01), while GOLD 3 group showed positive correlation between IL-6 and IL-10 (p <.01), IL-6 and total cholesterol (p <.01) and negative correlation between IL-10 and HDL-cholesterol (p =.01). Conclusion: Our findings suggest that patients with severe COPD can exhibit compromised “inflammatory status” characterized by higher IL6, IL-6/IL-10 ratio and lower IL-10 concentration. Furthermore, IL-10 seems to be an interesting cytokine to be investigated in this kind of patients.
publishDate 2018
dc.date.none.fl_str_mv 2018-12-11T17:34:44Z
2018-12-11T17:34:44Z
2018-06-01
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://dx.doi.org/10.1016/j.cyto.2017.10.018
Cytokine, v. 106, p. 95-100.
1096-0023
1043-4666
http://hdl.handle.net/11449/179329
10.1016/j.cyto.2017.10.018
2-s2.0-85032884673
2-s2.0-85032884673.pdf
6550959666011238
url http://dx.doi.org/10.1016/j.cyto.2017.10.018
http://hdl.handle.net/11449/179329
identifier_str_mv Cytokine, v. 106, p. 95-100.
1096-0023
1043-4666
10.1016/j.cyto.2017.10.018
2-s2.0-85032884673
2-s2.0-85032884673.pdf
6550959666011238
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Cytokine
1,433
1,433
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 95-100
application/pdf
dc.source.none.fl_str_mv Scopus
reponame:Repositório Institucional da UNESP
instname:Universidade Estadual Paulista (UNESP)
instacron:UNESP
instname_str Universidade Estadual Paulista (UNESP)
instacron_str UNESP
institution UNESP
reponame_str Repositório Institucional da UNESP
collection Repositório Institucional da UNESP
repository.name.fl_str_mv Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)
repository.mail.fl_str_mv
_version_ 1808129514697392128